Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANAPTYSBIO, INC Director's Dealing 2017

Feb 6, 2017

32596_dirs_2017-02-06_0ba58d85-bc98-4c21-94e6-bfbec8aa40a3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAPTYSBIO INC (ANAB)
CIK: 0001370053
Period of Report: 2017-02-02

Reporting Person: Frazier Healthcare VII, L.P. (10% Owner)
Reporting Person: Frazier Healthcare VII-A, L.P. (10% Owner)
Reporting Person: FHM VII, L.P. (10% Owner)
Reporting Person: FHM VII, L.L.C. (10% Owner)
Reporting Person: FRAZIER ALAN D (10% Owner)
Reporting Person: Naini Nader J (10% Owner)
Reporting Person: Every Nathan R (10% Owner)
Reporting Person: Heron Patrick J (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-02 Common Stock X 117235 $4.55 Acquired 2345612 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-02 Warrants $4.55 X 117235 Disposed 2018-11-04 Common Stock (117235) Indirect

Footnotes

F1: This warrant is exercisable at any time.

F2: Represents shares held by Frazier Healthcare V, L.P., an affiliate of Frazier Healthcare Partners. Each of the Reporting Persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.